About us
Contact
Location
News
World News
Clinical News
UK News
Get news headlines by email
JobSearch
Search
Manage job postings
Recruiters' Directory
Get jobs by email
Advertising rates
Contacts
Magazine
Latest issue
Search past issues
Search Corporate profiles
Free subscription
Have your say
Advertising
Contact
Awards and Events
European Marketeer
Marketeer
RBM
Representative
Clinical Researcher
Communications Team
Recruiter
Great Oxford Debate
Joint Working Projects
US Clinical Researcher
Clubs
SOPHIE
PharmaTimes Directors' Club
Find agency
Advertising
Recruitment
Advertise
Why advertise?
Website and Archive search
Go
JobSearch
Go
Email
Password
Login
Subscribe to the archive
Forgotten password
MAGAZINE AUDIT BY
Where am I? >
Home
>
Industry News
>
World News
LATEST WORLD NEWS
Solid results for Amgen but all eyes on denosumab
Amgen’s adjusted net income for the second quarter has edged up 1% to $1.33 billion, while turnover was up 2% to $3.80 billion
Merck KGaA earnings shoot up, profit forecast raised
Merck KGaA has posted a strong set of figures for the second quarter this morning, which reveal that earnings jumped 70.1%
Wellcome Trust and India team up for affordable drugs
The Wellcome Trust has extended its alliance with the Government of India’s Department of Biotechnology, this time setting up a £45 million partnership to develop “innovative healthcare products at affordable costs”
GSK pays out $15 million to option Anacor antibiotic
GlaxoSmithKline has exercised its option to develop an antibiotic from Anacor Pharmaceuticals which has shown potential in early-stage studies
NiCox still optimistic after naproxcinod failure in USA
Fresh from having its pain product naproxcinod rejected by the FDA, NicOx has posted its financial results for the first six months of 2010 which show that the French biotech is still in a reasonable state, cashwise
Strong quarter for AstraZeneca as FDA panel backs Brilinta
AstraZeneca shares are on the rise this morning after the firm posted a strong set of financials for the second quarter and celebrated a recommendation for approval from US advisory panel for its bloodthinner Brilinta
More Headlines
Solid results at Sanofi, plays down Genzyme bid
Bayer pharma earnings fall as R&D spend climbs
Servier could be hit with hefty fine for ‘misleading’ EU
FDA gives priority to Merck KGaA's MS pill
US patients “should have EU-approved drugs”
UK lags Europe in uptake of new cancer drugs, study shows
£50M more for cancer drugs in England from October to April
Teva earnings soar yet again, driven by Copaxone
Merck & Co signs China vaccines alliance
Sanofi looks to block generic Lovenox in court
FDA staffers pretty positive on AstraZeneca's Brilinta
GSK revamps system for paying sales reps
Older >
Join PharmaTimes Directors Club
Find out more
PharmaTimes Club for Directors Secretaries
Learn more
LATEST JOBS
Junior Editor, Healthcare Communications
Hospital Specialist - Northern & Western Home Counties
PRODUCT MANAGER - HOMECARE
Part-time Medical Representative
Medical Scientific Liaison Representative
Regional Account Manager/Business Manager
Territory Manger- North-West
GP/Hospital Representative
Product and Promotions Manager - Aesthetics
Consulting careers in International Life-Sciences Executive Search
Home
|
World News
|
Clinical News
|
UK News
|
Magazines
|
Competitions
|
Clubs
|
Jobs
|
Forums
|
Directory
RSS Feed
|
Advertising & Rates
|
About us
|
Contact
|
Subscribe
|
Privacy
|
Statistics
|
Maintained by DCSL